Linzess (Linaclotide)
A guanylate cyclase-C agonist indicated for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults On August 30, 2012, FDA approved linaclotide...
View ArticleIrritable bowel syndrome therapeutics market dynamics
Koutsokeras Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is...
View ArticleFDA drug approvals-May 2015
FDA actions in brief Sirolimus (Rapamune, Wyeth Pharmaceuticals) was approved to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age....
View ArticleNew peppermint oil formulation helps quiet IBS symptoms
A new formulation of peppermint oil, which will be available in June in major drug store chains, has been shown to relieve severe irritable bowel syndrome (IBS) symptoms in adults, including abdominal...
View Article
More Pages to Explore .....